KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-term Investments (2018 - 2020)

Elanco Animal Health's Short-term Investments history spans 3 years, with the latest figure at $11.0 million for Q4 2020.

  • For Q4 2020, Short-term Investments changed 0.0% year-over-year to $11.0 million; the TTM value through Dec 2020 reached $11.0 million, changed 0.0%, while the annual FY2020 figure was $11.0 million, 0.0% changed from the prior year.
  • Short-term Investments for Q4 2020 was $11.0 million at Elanco Animal Health, roughly flat from $11.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $634.9 million in Q3 2018 and bottomed at $11.0 million in Q4 2019.
  • The 3-year median for Short-term Investments is $11.0 million (2019), against an average of $94.4 million.
  • The largest annual shift saw Short-term Investments plummeted 98.25% in 2019 before it changed 0.0% in 2020.
  • A 3-year view of Short-term Investments shows it stood at $202.7 million in 2018, then tumbled by 94.57% to $11.0 million in 2019, then changed by 0.0% to $11.0 million in 2020.
  • Per Business Quant, the three most recent readings for ELAN's Short-term Investments are $11.0 million (Q4 2020), $11.0 million (Q3 2020), and $11.0 million (Q2 2020).